Extraordinary General Meeting 2018

The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, (“Oncopeptides” or the “Company”) are hereby given notice to attend the Extraordinary General Meeting to be held at Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm, Sweden, Wednesday 5 December 2018 at 3:00 p.m.

 

Coffee will be served starting at 2:00 p.m., at which time the registration for attendees will commence.

Upcoming events

ASCO 2021 Annual Meeting

-

American Society of Clinical Oncology (ASCO) 2021.

EHA 2021 Virtual Congress

-

European Hematology Association Annual meeting 2021.

Silent Period

-

Interim Report Q2 2021

08:00 CET

Silent Period

-

Interim Report Q3 2021

08:00 CET